[PDF][PDF] Longitudinal assessment of chemotherapy-induced structural changes in cerebral white matter and its correlation with impaired cognitive functioning
…, J Vandenberghe, M Vandenbulcke… - Journal of Clinical …, 2012 - researchgate.net
Purpose To uncover the neural substrate of cognitive impairment related to adjuvant
chemotherapy, we studied cerebral white matter (WM) integrity before and after chemotherapy by …
chemotherapy, we studied cerebral white matter (WM) integrity before and after chemotherapy by …
A Pan‐European Study of the C9orf72 Repeat Associated with FTLD: Geographic Prevalence, Genomic Instability, and Intermediate Repeats
…, M Vandenbulcke, M Vandenbulcke… - Human …, 2013 - Wiley Online Library
We assessed the geographical distribution of C9orf72 G 4 C 2 expansions in a pan‐ E
uropean frontotemporal lobar degeneration ( FTLD ) cohort (n = 1,205), ascertained by the E …
uropean frontotemporal lobar degeneration ( FTLD ) cohort (n = 1,205), ascertained by the E …
Recommendations to distinguish behavioural variant frontotemporal dementia from psychiatric disorders
…, F Gossink, E Vijverberg, E Huey, M Vandenbulcke… - Brain, 2020 - academic.oup.com
The behavioural variant of frontotemporal dementia (bvFTD) is a frequent cause of early-onset
dementia. The diagnosis of bvFTD remains challenging because of the limited accuracy …
dementia. The diagnosis of bvFTD remains challenging because of the limited accuracy …
Phase 1 study of the Pittsburgh compound B derivative 18F-flutemetamol in healthy volunteers and patients with probable Alzheimer disease
…, L Thurfjell, R Owenius, M Vandenbulcke… - Journal of Nuclear …, 2009 - Soc Nuclear Med
11 C-Pittsburgh compound B (PiB) marks Aβ amyloidosis, a key pathogenetic process in
Alzheimer disease (AD). The use of 11 C-PiB is limited to centers with a cyclotron. Development …
Alzheimer disease (AD). The use of 11 C-PiB is limited to centers with a cyclotron. Development …
Chemotherapy‐induced structural changes in cerebral white matter and its correlation with impaired cognitive functioning in breast cancer patients
…, J Vandenberghe, M Vandenbulcke… - Human brain …, 2011 - Wiley Online Library
A subgroup of patients with breast cancer suffers from mild cognitive impairment after
chemotherapy. To uncover the neural substrate of these mental complaints, we examined cerebral …
chemotherapy. To uncover the neural substrate of these mental complaints, we examined cerebral …
Age-related microstructural differences quantified using myelin water imaging and advanced diffusion MRI
Age-related microstructural differences have been detected using diffusion tensor imaging (DTI).
Although DTI is sensitive to the effects of aging, it is not specific to any underlying …
Although DTI is sensitive to the effects of aging, it is not specific to any underlying …
Whole-body biodistribution and radiation dosimetry of 18F-GE067: a radioligand for in vivo brain amyloid imaging
…, C Buckley, N Nelissen, M Vandenbulcke… - Journal of Nuclear …, 2009 - Soc Nuclear Med
We have characterized the biodistribution and dosimetry of 18 F-3′-F-6-OH-BTA1 ( 18 F-GE067),
a newly developed radioligand to visualize and quantify amyloid burden, in healthy …
a newly developed radioligand to visualize and quantify amyloid burden, in healthy …
A European multicentre PET study of fibrillar amyloid in Alzheimer's disease
…, K Van Laere, N Nelissen, M Vandenbulcke… - European journal of …, 2013 - Springer
Purpose Amyloid PET tracers have been developed for in vivo detection of brain fibrillar
amyloid deposition in Alzheimer’s disease (AD). To serve as an early biomarker in AD the …
amyloid deposition in Alzheimer’s disease (AD). To serve as an early biomarker in AD the …
Loss of TBK1 is a frequent cause of frontotemporal dementia in a Belgian cohort
…, B Heeman, S Engelborghs, M Vandenbulcke… - Neurology, 2015 - AAN Enterprises
Objective: To assess the genetic contribution of TBK1, a gene implicated in amyotrophic
lateral sclerosis (ALS), frontotemporal dementia (FTD), and FTD-ALS, in Belgian FTD and ALS …
lateral sclerosis (ALS), frontotemporal dementia (FTD), and FTD-ALS, in Belgian FTD and ALS …
Investigating the role of rare heterozygous TREM2 variants in Alzheimer's disease and frontotemporal dementia
…, J van der Zee, S Engelborghs, M Vandenbulcke… - Neurobiology of …, 2014 - Elsevier
Homozygous mutations in exon 2 of TREM2, a gene involved in Nasu-Hakola disease, can
cause frontotemporal dementia (FTD). Moreover, a rare TREM2 exon 2 variant (p.R47H) was …
cause frontotemporal dementia (FTD). Moreover, a rare TREM2 exon 2 variant (p.R47H) was …